Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J0893 |
Short Description | Inj, decitabine (sun pharma) |
Long Description | Injection, decitabine (sun pharma) not therapeutically equivalent to j0894, 1 mg |
Pricing indicator | 51 |
Coverage code | C |
ASC payment group code | YY |
BETOS2 code | O1E |
Action code | P |
Type of service | 1 |
Effective date | 2024-01-01 |
Date Added | 2023-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
47335036141 | J0893 | Inj, decitabine (sun pharma) | decitabine | SUN PHARMACEUTICAL GLOBAL FZE. | 1 MG | 1 | 1 | 50 | 50 |
HCPCS Billing Calculator
Dosage given to patient (per dose) | |
---|---|
HCPCS Dosage | 1 MG |
HCPCS/CPT Billing Units | 1 |
Total doses ordered | |
Billing Units | 1 |
Drug Details
-
Decitabine is used to treat myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and does not produce enough healthy blood cells). Decitabine is in a class of medications called hypomethylation agents. It works by helping the bone marrow produce normal blood cells and by killing abnormal cells in the bone marrow.